PRESS-RELEASE ·Filed May 20, 2026
Press release: activist
Actionable Insight • Neutral
No material event for traders. The grants are routine and do not change the company's outlook. Monitor Dyne's pipeline updates for DMD and DM1 for future catalysts.
Final — all horizons settled through T+60d
DYN ▲ +50.55% at T+60d
NEUTRAL call ✓ call won +50.55% · α vs SPY +46.25% · entry $17.37 → $26.15
T+1d
0.00%
call 0.00% · α -0.45%
$17.37
settled 4mo ago
T+5d
+6.85%
call +6.85% · α +5.25%
$18.56
settled 4mo ago
T+20d
+20.15%
call +20.15% · α +19.82%
$20.87
settled 4mo ago
T+60d
+50.55%
call +50.55% · α +46.25%
$26.15
settled 7w ago
Price Chart
Loading chart...
Executive Summary
Dyne Therapeutics granted inducement equity awards to 17 newly hired employees, consisting of stock options for 296,500 shares and RSUs for 94,100 shares, vesting over four years. This is a routine compensation action with no material financial impact.
Key Facts
- Inducement grants to 17 new employees.
- Stock options for 296,500 shares at closing price.
- RSUs for 94,100 shares.
- Both award types vest over four years.
Financial Impact
Minimal; equity grants are standard for new hires and do not reflect operational performance.
dilution
Risk Factors
- No new risks identified from this filing.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3298933 |
44 reports for DYN
87% Hit rate best @ T+60▲ +46.36%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.18 (+41.97%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.18 (−41.97%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.18 (+40.95%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.18 (−40.95%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.18 (−40.95%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.18 (−41.02%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.18 (+34.62%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.18 (−35.29%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.18 (−30.36%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.18 (+31.67%) |
Showing 10 of 44
US Market Status
Market Open — Closes in 20m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access